MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results

Authors

Institutions

Publication Details

Journal
CardioVascular and Interventional Radiology
Published
2025-09-22
DOI
https://doi.org/10.1007/s00270-025-04202-8
Citations
3
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
6.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results

Andrej Schmidt, Michel Bosiers, Nasser Malyar, Raman Uberoi et al.
3 citations
CardioVascular and Interventional Radiology
Peripheral Artery Disease Management
6.02
article

MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results

Andrej Schmidt, Michel Bosiers, Nasser Malyar, Raman Uberoi, Dierk Scheinert, Henrik Schrøeder, Thomas Rand
article en
3 citations

Abstract

No abstract available for this paper.
CardioVascular and Interventional RadiologyVol. 48(11)
University Hospital of Bern (CH), John Radcliffe Hospital (GB), Institute for Interdisciplinary Studies of Austrian Universities (AT), University Hospital Münster (DE), University Hospital Leipzig (DE), Oxford University Hospitals NHS Trust (GB), St. Franziskus Hospital (DE), Karl Landsteiner Society (AT), Jewish Hospital (US)
Openalex Percentile: Top 3%
Peripheral Artery Disease Management
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results — Andrej Schmidt, Michel Bosiers, et al. · CardioVascular and Interventional Radiology (2025) | TGRS Research Map | TGRS